BioNTech SE es una empresa de biotecnología alemana dedicada al desarrollo y fabricación de inmunoterapias activas para un enfoque específico del paciente en el tratamiento de enfermedades graves. Wikipedia
Fundadores: Uğur Şahin, Özlem Türeci y Christoph Huber
Director ejecutivo: Uğur Şahin (2008–)
Filiales: InstaDeep Ltd, BioNTech US Inc., Aexerna Therapeutics y más
Fundación: 2008
Oficinas centrales: Alemania
Fuente: S&P Capital IQ
We strive to exploit the full potential of the body's immune system by combining powerful new therapeutic mechanisms and a diverse array of biological targets ...
Más preguntas
Why are BioNTech stocks falling?
Did Pfizer buy BioNTech?
What does BioNTech do?
Is BioNTech a good company to work for?
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the ...
Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, ...
Our aim is to provide therapeutic benefits for cancer patients along the entire treatment journey. https://investors.biontech.de/news-releases/news-release- ...
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to ...
BioNTech SE | 236128 followers on LinkedIn. Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious ...
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) Authorized For Individuals 6 Months through 11 Years of Age.